Q4 2023 Holdings
Filed 2024-02-14 | 69 holdings | $734.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $1.2M | 500,000 | 0.2% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $1.9M | 100,000 | 0.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $2.0M | 100,000 | 0.3% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $2.2M | 100,000 | 0.3% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $2.2M | 150,000 | 0.3% |
| Patterson COS Inc(PDCOEUR) | COM | 703395103 | $2.8M | 100,000 | 0.4% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $3.4M | 900,000 | 0.5% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $3.8M | 250,000 | 0.5% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $4.0M | 450,000 | 0.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.1M | 130,000 | 0.6% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $4.1M | 325,000 | 0.6% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $4.3M | 450,000 | 0.6% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.3M | 200,000 | 0.6% |
| Avantor Inc(AVTR) | COM | 05352A100 | $4.6M | 200,000 | 0.6% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $5.4M | 900,000 | 0.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $5.7M | 200,000 | 0.8% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $5.8M | 325,000 | 0.8% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $6.5M | 100,000 | 0.9% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $6.6M | 600,000 | 0.9% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $6.6M | 315,000 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $6.9M | 249,000 | 0.9% |
| Illumina Inc(ILMN) | COM | 452327109 | $7.0M | 50,000 | 0.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $7.1M | 200,000 | 1.0% |
| Hologic Inc(HOLX) | COM | 436440101 | $7.1M | 100,000 | 1.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.2M | 175,000 | 1.0% |
| Bruker Corp(BRKR) | COM | 116794108 | $7.3M | 100,000 | 1.0% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $7.5M | 500,000 | 1.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $7.6M | 375,000 | 1.0% |
| Align Technology Inc(ALGN) | COM | 016255101 | $8.2M | 30,000 | 1.1% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $8.3M | 250,000 | 1.1% |
| Cytokinetics Inc(CYTK)Put | COM NEW | 23282W605 | $8.3M | 100,000 | 1.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.6M | 45,000 | 1.2% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $8.9M | 160,000 | 1.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $9.3M | 500,000 | 1.3% |
| Elevance Health Inc(ELV) | COM | 036752103 | $9.4M | 20,000 | 1.3% |
| Centene Corp del(CNC) | COM | 15135B101 | $9.6M | 130,000 | 1.3% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $9.9M | 120,000 | 1.3% |
| Repligen Corp(RGEN) | COM | 759916109 | $9.9M | 55,000 | 1.3% |
| Icon PLC(ICLR) | SHS | G4705A100 | $9.9M | 35,000 | 1.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $10.1M | 40,000 | 1.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $10.5M | 85,000 | 1.4% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $10.7M | 70,000 | 1.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $10.8M | 350,000 | 1.5% |
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $11.4M | 50,000 | 1.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $11.8M | 520,000 | 1.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $11.9M | 90,000 | 1.6% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $12.2M | 100,000 | 1.7% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $12.2M | 60,000 | 1.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $12.5M | 175,000 | 1.7% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $12.9M | 140,000 | 1.8% |